Barbaro, M. R., Bianco, F., Cremon, C., Marasco, G., Stanghellini, V., & Barbara, G. (2025). A probiotic mixture of Lactobacillus rhamnosus LR 32, Bifidobacterium lactis BL 04, and Bifidobacterium longum BB 536 counteracts the increase in permeability induced by the mucosal mediators of irritable bowel syndrome by acting on Zonula Occludens 1. International Journal of Molecular Sciences, 26(6), 2656.
Everhart, J. E. (2008). Functional intestinal disorders: The burden of digestive diseases in the United States. NIH.
Han, X., Ding, S., Ma, Y., Fang, J., Jiang, H., & Li, Y. (2021). Lactobacillus plantarum and Lactobacillus brevis alleviate intestinal
inflammation and microbial disorder induced by ETEC in a murine model. Oxidative Medicine and Cellular Longevity, 2021, 6867962.
Marchbank, T., Davison, G., Oakes, J. R., Ghatei, M. A., Patterson, M., Moyer, M. P., & Playford, R. J. (2011). The nutriceutical bovine colostrum truncates the increase in gut permeability caused by heavy exercise in athletes. American Journal of Physiology-Gastrointestinal and Liver Physiology, 300(3), 477–484.
Ojetti, V., Petruzziello, C., Migneco, A., Gnarra, M., Gasbarrini, A., & Franceschi, F. (2017). Effect of Lactobacillus reuteri (DSM 17938) on
methane production in patients affected by functional constipation. European Review for Medical and Pharmacological Sciences, 21(7), 1702–1708.
Okeniyi, J. A. O., Ogunlesi, T. A., Oyelami, O. A., & Adeyemi, L. A. (2007). Effectiveness of dried carica papaya seeds against human intestinal parasitosis: A pilot study. Journal of Medicinal Food, 10(1), 194–196.
Oliveira, M., Bosco, N., Perruisseau, G., Nicolas, J., Segura-Roggero, I., Duboux, S., Briand, M., Blum, S., & Benyacoub, J. (2011). Lactobacillus paracasei reduces intestinal inflammation in adoptive transfer mouse model of experimental colitis. Clinical and Developmental Immunology, 2011, 807483.
Pourramezan, Z., Oloomi, M., & Kasra-Kermanshahi, R. (2020). Antioxidant and anticancer activities of Lactobacillus hilgardii strain AG12a. International Journal of Preventive Medicine, 11(1), 132–132.
Schepper, J. D., Collins, F. L., Rios-Arce, N. D., Raehtz, S., Schaefer, L., Gardinier, J. D., Britton, R. A., Parameswaran, N., & McCabe, L. R. (2019). Probiotic Lactobacillus reuteri prevents postantibiotic bone loss by reducing intestinal dysbiosis and preventing barrier disruption. Journal of Bone and Mineral Research, 34(4), 681–698.
Riezzo, G., Orlando, A., D’Attoma, B., Linsalata, M., Martulli, M., & Russo, F. (2018). Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: Improvement in symptoms and bowel habit in functional constipation. Beneficial Microbes, 9(1), 51–60.
Venkataraman, B., Almarzooqi, S., Raj, V., Alhassani, A. T., Alhassani, A. S., Ahmed, K. J., Subramanian, V. S., Ojha, S. K., Attoub, S., Adrian, T. E., & Subramanya, S. B. (2021). Thymoquinone, a dietary bioactive compound, exerts anti-inflammatory effects in colitis by stimulating expression of the colonic epithelial PPAR-γ transcription factor. Nutrients, 13(4), 1343.
Yang, Y., Wang, Y., Cao, X., Shi, L., & Wang, Y. (2024). Lactobacillus buchneri ameliorates obesity-related disorders induced by high-fat and high-cholesterol diet in mice. Food and Humanity, 3(19), 100317.
Zeng, X. Q., Pan, D. D., & Guo, Y. X. (2009). The probiotic properties of Lactobacillus buchneri P2. Journal of Applied Microbiology, 108(6), 2059–2066.
Gut Save Label
